301 related articles for article (PubMed ID: 29338045)
1. Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein.
Kim AR; Lee DH; Lee SH; Rubino I; Choi HJ; Quan FS
PLoS One; 2018; 13(1):e0191277. PubMed ID: 29338045
[TBL] [Abstract][Full Text] [Related]
2. Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus.
Blanco JCG; Fernando LR; Zhang W; Kamali A; Boukhvalova MS; McGinnes-Cullen L; Morrison TG
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511382
[TBL] [Abstract][Full Text] [Related]
3. Chimeric virus-like particles containing a conserved region of the G protein in combination with a single peptide of the M2 protein confer protection against respiratory syncytial virus infection.
Qiao L; Zhang Y; Chai F; Tan Y; Huo C; Pan Z
Antiviral Res; 2016 Jul; 131():131-40. PubMed ID: 27154395
[TBL] [Abstract][Full Text] [Related]
4. A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus.
Jiao YY; Fu YH; Yan YF; Hua Y; Ma Y; Zhang XJ; Song JD; Peng XL; Huang J; Hong T; He JS
Antiviral Res; 2017 Aug; 144():57-69. PubMed ID: 28529001
[TBL] [Abstract][Full Text] [Related]
5. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
[TBL] [Abstract][Full Text] [Related]
6. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM
Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590
[TBL] [Abstract][Full Text] [Related]
7. Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice.
Quan FS; Kim Y; Lee S; Yi H; Kang SM; Bozja J; Moore ML; Compans RW
J Infect Dis; 2011 Oct; 204(7):987-95. PubMed ID: 21881112
[TBL] [Abstract][Full Text] [Related]
8. Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus.
Terhüja M; Siddappa M; Lamichhane P; Meshram CD; Snider TA; Ritchey JW; Oomens AGP
Viruses; 2024 May; 16(6):. PubMed ID: 38932136
[TBL] [Abstract][Full Text] [Related]
9. Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.
Hwang HS; Kim KH; Lee Y; Lee YT; Ko EJ; Park S; Lee JS; Lee BC; Kwon YM; Moore ML; Kang SM
Hum Vaccin Immunother; 2017 May; 13(5):1031-1039. PubMed ID: 28129031
[TBL] [Abstract][Full Text] [Related]
10. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
[TBL] [Abstract][Full Text] [Related]
11. Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.
Murawski MR; McGinnes LW; Finberg RW; Kurt-Jones EA; Massare MJ; Smith G; Heaton PM; Fraire AE; Morrison TG
J Virol; 2010 Jan; 84(2):1110-23. PubMed ID: 19889768
[TBL] [Abstract][Full Text] [Related]
12. Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins.
Lee S; Quan FS; Kwon Y; Sakamoto K; Kang SM; Compans RW; Moore ML
Antiviral Res; 2014 Nov; 111():129-35. PubMed ID: 25239522
[TBL] [Abstract][Full Text] [Related]
13. Two RSV Platforms for G, F, or G+F Proteins VLPs.
Ha B; Yang JE; Chen X; Jadhao SJ; Wright ER; Anderson LJ
Viruses; 2020 Aug; 12(9):. PubMed ID: 32824936
[TBL] [Abstract][Full Text] [Related]
14. The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate.
McGinnes Cullen L; Luo B; Wen Z; Zhang L; Durr E; Morrison TG
J Virol; 2023 Jan; 97(1):e0190022. PubMed ID: 36602367
[TBL] [Abstract][Full Text] [Related]
15. Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.
Hwang HS; Lee YT; Kim KH; Park S; Kwon YM; Lee Y; Ko EJ; Jung YJ; Lee JS; Kim YJ; Lee YN; Kim MC; Cho M; Kang SM
Virology; 2016 Jul; 494():215-24. PubMed ID: 27123586
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model.
Blanco JCG; Pletneva LM; McGinnes-Cullen L; Otoa RO; Patel MC; Fernando LR; Boukhvalova MS; Morrison TG
Nat Commun; 2018 May; 9(1):1904. PubMed ID: 29765035
[TBL] [Abstract][Full Text] [Related]
17. Modification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory.
Schmidt MR; McGinnes-Cullen LW; Kenward SA; Willems KN; Woodland RT; Morrison TG
J Virol; 2014 Sep; 88(17):10165-76. PubMed ID: 24965456
[TBL] [Abstract][Full Text] [Related]
18. Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein.
Cullen LM; Blanco JC; Morrison TG
J Transl Med; 2015 Nov; 13():350. PubMed ID: 26541285
[TBL] [Abstract][Full Text] [Related]
19. Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins.
McGinnes LW; Gravel KA; Finberg RW; Kurt-Jones EA; Massare MJ; Smith G; Schmidt MR; Morrison TG
J Virol; 2011 Jan; 85(1):366-77. PubMed ID: 20980510
[TBL] [Abstract][Full Text] [Related]
20. Construction and immunological evaluation of hepatitis B virus core virus-like particles containing multiple antigenic peptides of respiratory syncytial virus.
Lei L; Qin H; Luo J; Tan Y; Yang J; Pan Z
Virus Res; 2021 Jun; 298():198410. PubMed ID: 33819519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]